Intermediate-Size Expanded Access Protocol (EAP) for LP352

NCT06149663 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Dravet Syndrome
Lennox Gastaut Syndrome
Developmental and Epileptic Encephalopathies

Interventions

DRUG: LP352

Sponsor

Longboard Pharmaceuticals